TGFB1 and fibrosis: AGEs enhance ECM production by inhibiting cell death in TGF-β1-activated HSCs and mediating aberrant crosslinking in the liver extracellular matrix, ultimately contributing to the development of fibrosis/cirrhosis [32, 33].